Pre-clinical models of genetically heterogeneous multiple myeloma reveal mechanisms of immune escape and predict clinical immunotherapy outcomes

被引：0

作者：

Larrayoz, Marta ^{[1
]}

Garcia-Barchino, Maria J. ^{[1
]}

Celay, Jon ^{[1
]}

Etxebeste, Amaia ^{[1
]}

Jimenez, Maddalen ^{[1
]}

Perez, Cristina ^{[1
]}

Ordonez, Raquel ^{[1
]}

Cobaleda, Cesar ^{[2
]}

Chesi, Marta ^{[3
]}

Bergsagel, Leif ^{[3
]}

Rodriguez-Otero, Paula ^{[4
]}

Takahashi, Satoru ^{[5
]}

Katz, Samuel G. ^{[6
]}

Walensky, Loren D. ^{[7
]}

Ruppert, Shannon M. ^{[8
]}

Lasater, Elisabeth A. ^{[8
]}

Amann, Maria ^{[9
]}

Lasarte, Juan J. ^{[1
]}

Kurilovich, Anna ^{[10
]}

Cerchietti, Leandro ^{[11
]}

Agirre, Xabier ^{[1
]}

San-Miguel, Jesus ^{[12
]}

Paiva, Bruno ^{[12
]}

Prosper, Felipe ^{[13
]}

Martinez-Climent, Jose A. ^{[1
]}

机构：

[1] Univ Navarra, Pamplona, Spain

[2] Univ Autonoma, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain

[3] Mayo Clin, Rochester, MN USA

[4] Clin Univ Navarra, CIMA, IDISNA, CIBERONC, Navarra, Spain

[5] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan

[6] Yale Sch Med, New Haven, CT USA

[7] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[8] Genentech Inc, San Francisco, CA USA

[9] Roche Innovat Ctr Zurich, Zurich, Switzerland

[10] Bostongene Corp, Waltham, MA USA

[11] Weill Cornell Med, New York, NY USA

[12] Clin Univ Navarra, Inst Invest Sanitaria Navarra IDISNA, Ctr Invest Med Aplicada CIMA, CCUN,CIBER ONC, Pamplona, Spain

[13] Clin Univ Navarra, Pamplona, Spain

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OAB-033

引用

页码：S19 / S20

页数：2

共 50 条

[1] Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Larrayoz, Marta
Garcia-Barchino, Maria J.
Celay, Jon
Etxebeste, Amaia
Jimenez, Maddalen
Perez, Cristina
Ordonez, Raquel
Cobaleda, Cesar
Botta, Cirino
Fresquet, Vicente
Roa, Sergio
Goicoechea, Ibai
Maia, Catarina
Lasaga, Miren
Chesi, Marta
Bergsagel, P. Leif
Larrayoz, Maria J.
Calasanz, Maria J.
Campos-Sanchez, Elena
Martinez-Cano, Jorge
Panizo, Carlos
Rodriguez-Otero, Paula
Vicent, Silvestre
Roncador, Giovanna
Gonzalez, Patricia
Takahashi, Satoru
Katz, Samuel G.
Walensky, Loren D.
Ruppert, Shannon M.
Lasater, Elisabeth A.
Amann, Maria
Lozano, Teresa
Llopiz, Diana
Sarobe, Pablo
Lasarte, Juan J.
Planell, Nuria
Gomez-Cabrero, David
Kudryashova, Olga
Kurilovich, Anna
Revuelta, Maria V.
Cerchietti, Leandro
Agirre, Xabier
San Miguel, Jesus
Paiva, Bruno
Prosper, Felipe
Martinez-Climent, Jose A.
NATURE MEDICINE, 2023, 29 (3) : 632 - 645
[2] Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Marta Larrayoz
Maria J. Garcia-Barchino
Jon Celay
Amaia Etxebeste
Maddalen Jimenez
Cristina Perez
Raquel Ordoñez
Cesar Cobaleda
Cirino Botta
Vicente Fresquet
Sergio Roa
Ibai Goicoechea
Catarina Maia
Miren Lasaga
Marta Chesi
P. Leif Bergsagel
Maria J. Larrayoz
Maria J. Calasanz
Elena Campos-Sanchez
Jorge Martinez-Cano
Carlos Panizo
Paula Rodriguez-Otero
Silvestre Vicent
Giovanna Roncador
Patricia Gonzalez
Satoru Takahashi
Samuel G. Katz
Loren D. Walensky
Shannon M. Ruppert
Elisabeth A. Lasater
Maria Amann
Teresa Lozano
Diana Llopiz
Pablo Sarobe
Juan J. Lasarte
Nuria Planell
David Gomez-Cabrero
Olga Kudryashova
Anna Kurilovich
Maria V. Revuelta
Leandro Cerchietti
Xabier Agirre
Jesus San Miguel
Bruno Paiva
Felipe Prosper
Jose A. Martinez-Climent
Nature Medicine, 2023, 29 : 632 - 645
[3] Melphalan and XPO1 inhibition are synergistic in pre-clinical models of multiple myeloma
Turner, Joel G.
Dawson, Jana L.
Sullivan, Daniel M.
CANCER RESEARCH, 2016, 76
[4] Immune Checkpoint Inhibitors: Cardiotoxicity in Pre-clinical Models and Clinical Studies
Xu, Shirley
Sharma, Umesh C.
Tuttle, Cheyanna
Pokharel, Saraswati
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[5] Immune characterization of pre-clinical murine models of neuroblastoma
Emily R. Webb
Silvia Lanati
Carol Wareham
Alistair Easton
Stuart N. Dunn
Tatyana Inzhelevskaya
Freja M. Sadler
Sonya James
Margaret Ashton-Key
Mark S. Cragg
Stephen A. Beers
Juliet C. Gray
Scientific Reports, 10
[6] Immune characterization of pre-clinical murine models of neuroblastoma
Webb, Emily R.
Lanati, Silvia
Wareham, Carol
Easton, Alistair
Dunn, Stuart N.
Inzhelevskaya, Tatyana
Sadler, Freja M.
James, Sonya
Ashton-Key, Margaret
Cragg, Mark S.
Beers, Stephen A.
Gray, Juliet C.
SCIENTIFIC REPORTS, 2020, 10 (01)
[7] Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
Herold, Betsy C.
RETROVIROLOGY, 2006, 3
[8] Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
Betsy C Herold
Retrovirology, 3 (Suppl 1)
[9] Systemic effects of radiotherapy: immune mechanisms, pre-clinical data and clinical evidence
Gaipl, U.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S5 - S5
[10] Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
Leng, Houfu
Zhang, Hanlin
Li, Linsen
Zhang, Shuhao
Wang, Yanping
Chavda, Selina J.
Galas-Filipowicz, Daria
Lou, Hantao
Ersek, Adel
Morris, Emma V.
Sezgin, Erdinc
Lee, Yi-Hsuan
Li, Yunsen
Lechuga-Vieco, Ana Victoria
Tian, Mei
Mi, Jian-Qing
Yong, Kwee
Zhong, Qing
Edwards, Claire M.
Simon, Anna Katharina
Horwood, Nicole J.
NATURE COMMUNICATIONS, 2022, 13 (01)

← 1 2 3 4 5 →